NCT04937920View on ClinicalTrials.gov

A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

September 20, 2021

Study Completion Date

November 4, 2021

Conditions
Tinea Versicolor
Interventions
BIOLOGICAL

DBI-002 probiotic gel

Topical application on skin affected with tinea versicolor

BIOLOGICAL

Aqueous gel

Topical application on skin affected with tinea versicolor

Trial Locations (1)

Unknown

Zepeda Dermatologia, Santa Tecla

Sponsors

Lead Sponsor

DermBiont, Inc.
All Listed Sponsors
lead

DermBiont, Inc.

INDUSTRY